ClinicalTrials.Veeva

Menu

Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery (SMART ANGEL 2)

C

Centre Hospitalier Universitaire de Nīmes

Status

Unknown

Conditions

Ambulatory Surgery

Treatments

Other: Smart Angel

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04068584
CIVI/2018/PC-01

Details and patient eligibility

About

The investigators hypothesize that by monitoring and analyzing physiological parameters (heart rate, blood pressure, saturation) and well-being (pain, nausea, vomiting, comfort) the SMART ANGEL ™ device improves the quality of care after major or intermediate outpatient surgery. This active surveillance will result in a decrease in the rate of unplanned recourse (hospitalization, consultation, telephone call).

Enrollment

1,260 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient must have given their free and informed consent and signed the consent form

  • The patient must be a member or beneficiary of a health insurance plan

  • The patient is undergoing ambulatory surgery for:

    • in orthopedics: shoulder (arthroscopy, abutment, prosthesis), hip (prosthesis, arthrolysis), knee (osteotomy, ligamentoplasty), ankle (prosthesis, ligamentoplasty) foot (hallux valgus); removal of major or multi-site equipment;
    • digestive (cholecystectomy, hernia repair, partial gastrectomy, colectomy, cleaning);
    • in gynecology (hysterectomy, oophorectomy, mastectomy, quadrantectomy, dissection, cystoplasty, sphincter);
    • in urology (total or partial resection of the prostate);
    • ENT (thyroidectomy, tonsillectomy);
    • Neurosurgery (herniated disc);
    • Vascular (stripping varix, creating fistula).
  • The patient has sufficient intellectual and cognitive capacity to use the devices

  • The patient must pass the test performed during the anesthesia consultation, namely:

    • open and connect the tablet,
    • activate the measurement of the blood pressure and the measurement of the oxygen saturation,
    • be connected to a 4G network

Exclusion criteria

  • The subject is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The patient is pregnant
  • The patient is undergoing emergency or minor surgery
  • Patient has a psychological class ASA 5
  • Patient is non-eligible for ambulatory surgery for medical reasons (decompensated medical pathology) or social reasons according to the criteria defined by the société française anesthésie réanimation. Person lives alone or has a geographical distance from a hospital center> 30 km (or> 45 min by car).
  • Patient who doesn't classify for ambulatory surgery at time of discharge

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,260 participants in 3 patient groups

Complete Smart Angel
Experimental group
Description:
Smat Angel application with artificial intelligence
Treatment:
Other: Smart Angel
Basic Smart Angel
Experimental group
Description:
Smat Angel application without artificial intelligence
Treatment:
Other: Smart Angel
Control
No Intervention group

Trial contacts and locations

24

Loading...

Central trial contact

Christophe Boisson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems